<DOC>
	<DOCNO>NCT00300313</DOCNO>
	<brief_summary>Assessing efficacy escitalopram preventing development PTSD , reduce severeness , exposure traumatic event .</brief_summary>
	<brief_title>PTSD Prevention Using Escitalopram</brief_title>
	<detailed_description />
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>1 . The patient able read understand Patient Informed Consent . 2 . The patient sign Patient Informed Consent . 3 . The patient sufficient knowledge Hebrew order understand study procedure instrument 4 . The patient male female age 18 65 year ( extremes include ) . 5 . The patient underwent traumatic event , vehicle accident , terror attack , physical sexual assault within last 3 week , 4 week ago . 6 . The patient meet either follow criterion : 1 . Full DSMIV criterion ASD 2 . Intrusion hyperarousal criterion 1 . The patient refuse medication therapy . This patient refer another treatment outside study frame . 2 . The patient serious physical injury inclusion , Abbreviated Injury Scale ( AIS ) score , least one body region , 3 , accord judgment clinician injury sequela would interfere study treatment . 3 . The patient us concomitant medication allow study : 1 . Antidepressants , include MAOI , RIMA within last 3 week prior screen . 2 . Mood stabilizer within last 3 week prior screen . 3 . Antipsychotic medication within last 3 week prior screen . 4 . Anxiolytics 2 week row randomization . Patient participate study take medication 3 day two week randomization . Except oxazepam 1020 mg/day 7 day raw . 5 . Serotonergic agonist ( e.g . triptans ) within last 2 week prior screen . 6 . Prophylactic treatment anticonvulsant drug . 7 . Herbal remedy psychoactive ( e.g . St John 's Wort , Kava kava , valerian , gingko biloba ) within last 3 week prior screen . 4 . The patient meet lifetime DSMIVTR criterion : 1 . Mania Bipolar disorder 2 . Schizophrenia 3 . Any personality disorder judge investigator jeopardize evaluation treatment . 4 . Mental retardation pervasive disorder 5 . Cognitive disorder ( inc. dementia ) 5 . The patient alcohol drug abuse relate disorder last year prior screen visit . 6 . The patient , investigator 's opinion , significant suicide risk and/or score â‰¥ 5 question 10 MADRS scale . 7 . The patient history severe suicide attempt . 8 . The patient require ElectroConvulsive Therapy ( ECT ) receive ECT within last year prior screen visit . 9 . The patient currently serve Israeli security force . 10 . The patient history drug allergy hypersensitivity , know hypersensitivity escitalopram citalopram . 11 . The patient illness and/or serious sequela thereof , severe enough accord clinician judgment , prevent participation study , include liver renal insufficiency ; cardiovascular , pulmonary , gastrointestinal , endocrine ( inc. uncontrolled thyroid ) , neurological ( inc. epilepsy ) , infectious , neoplastic , metabolic disturbance 12 . The patient pregnant breastfeeding . 13 . The patient , woman childbearing potential , use adequate contraception ( adequate contraception define sexual abstinence , oral/systemic contraception , surgical sterilisation , intrauterine device , diaphragm combination spermicide , condom male partner combination spermicide ) . 14 . The patient , opinion investigator , unlikely comply clinical study protocol . 15 . The patient previously participate current study study within last 30 day . 16 . The patient familial relationship investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>